---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282682379.md"
description: "Sana Biotechnology shares are trading higher after the company announced a strategic collaboration with Mayo Clinic to advance development of SC451. Also, the company sold 7.5 million shares at $3.33 per share for $25 million to Mayo Clinic."
datetime: "2026-04-13T20:18:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282682379.md)
  - [en](https://longbridge.com/en/news/282682379.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282682379.md)
---

# 

Sana Biotechnology shares are trading higher after the company announced a strategic collaboration with Mayo Clinic to advance development of SC451. Also, the company sold 7.5 million shares at $3.33 per share for $25 million to Mayo Clinic.

### Related Stocks

- [SANA.US](https://longbridge.com/en/quote/SANA.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data](https://longbridge.com/en/news/286652611.md)
- [Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition](https://longbridge.com/en/news/286608288.md)